RECAPTURE RATES WITH IXEKIZUMAB AFTER WITHDRAWAL OF THERAPY IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: RESULTS AT WEEK 104 FROM A RANDOMIZED PLACEBO-CONTROLLED WITHDRAWAL STUDY

被引：0
|
作者：
Landewe, Robert B. M. [1 ]
Poddubnyy, Denis [2 ]
Rahman, Proton [3 ]
Bolce, Rebecca [4 ]
Liu-Leage, Soyi [4 ]
Lisse, Jeffrey [4 ]
Leung, Ann [5 ]
Park, So Young [4 ]
Gensler, Lianne S. [6 ]
Bird, Paul [7 ]
机构：
[1] Amsterdam Rheumatol & Immunol Ctr, Dept Clin Immunol & Rheumatol, Amsterdam, Netherlands
[2] Charite, Hindenburgdamm, Germany
[3] Mem Univ Newfoundland, St John, NF, Canada
[4] Eli Lilly & Co, Indianapolis, IN 46285 USA
[5] Syneos Hlth, Morrisville, NY USA
[6] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[7] Conjoint Prof UNSW, Sydney, NSW, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2023年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
ARA-P70
引用
收藏
页码：37 / 38
页数：2
相关论文
共 50 条
  • [21] Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial
    Deodhar, Atul
    van der Heijde, Desiree
    Gensler, Lianne S.
    Kim, Tae-Hwan
    Maksymowych, Walter P.
    Ostergaard, Mikkel
    Poddubnyy, Denis
    Marzo-Ortega, Helena
    Bessette, Louis
    Tomita, Tetsuya
    Leung, Ann
    Hojnik, Maja
    Gallo, Gaia
    Li, Xiaoqi
    Adams, David
    Carlier, Hilde
    Sieper, Joachim
    LANCET, 2020, 395 (10217): : 53 - 64
  • [22] A Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of Subcutaneous Golimumab in Patients with Active Nonradiographic Axial Spondyloarthritis.
    Sieper, J.
    van der Heijde, D.
    Dougados, M.
    Maksymowych, W.
    Boice, J.
    Bergman, G.
    Curtis, S.
    Tzontcheva, A.
    Huyck, S.
    Weng, H. H.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1283 - S1284
  • [23] A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance of efficacy in patients with schizophrenia
    Tandon, R.
    Loebel, A.
    Phillips, D.
    Pikalov, A.
    Hernandez, D.
    Mao, Y.
    Cucchiaro, J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 153 - 154
  • [24] A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL STUDY OF LURASIDONE FOR THE MAINTENANCE OF EFFICACY IN PATIENTS WITH SCHIZOPHRENIA
    Tandon, Rajiv
    Loebel, Antony
    Phillips, Debra
    Pikalov, Andrei
    Hernandez, David
    Mao, Yongcai
    Cucchiaro, Josephine
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S372 - S372
  • [25] A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance of efficacy in patients with schizophrenia
    Tandon, Rajiv
    Cucchiaro, Josephine
    Phillips, Debra
    Hernandez, David
    Mao, Yongcai
    Pikalov, Andrei
    Loebel, Antony
    JOURNAL OF PSYCHOPHARMACOLOGY, 2016, 30 (01) : 69 - 77
  • [26] A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL STUDY OF LURASIDONE FOR THE MAINTENANCE OF EFFICACY IN PATIENTS WITH SCHIZOPHRENIA
    Tandon, R.
    Loebel, A.
    Phillips, D.
    Pikalov, A.
    Hernandez, D.
    Mao, Y.
    Cucchiaro, J.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [27] Feasibility of a Placebo-Controlled, Randomized Mesalamine Withdrawal Study in Children and Adolescents With Ulcerative Colitis
    Croft, Nick M.
    Faubion, William
    Tierens, Danielle
    Dewulf, Jocelyne
    Bwirire, Dieudonne
    Stefani-Hunyady, Diana
    Cataldi, Fabio
    GASTROENTEROLOGY, 2016, 150 (04) : S590 - S591
  • [28] A Randomized, Double-Blind, Placebo-Controlled Dose Range Study of Dexmedetomidine as Adjunctive Therapy for Alcohol Withdrawal*
    Mueller, Scott W.
    Preslaski, Candice R.
    Kiser, Tyree H.
    Fish, Douglas N.
    Lavelle, James C.
    Malkoski, Stephen P.
    MacLaren, Robert
    CRITICAL CARE MEDICINE, 2014, 42 (05) : 1131 - 1139
  • [29] SAFETY PROFILE OF BIMEKIZUMAB AT WEEK 16 IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS: RESULTS FROM FOUR PLACEBO-CONTROLLED PHASE 3 STUDIES
    Poddubnyy, D.
    Gensler, L. S.
    Mease, P. J.
    Orbai, A. M.
    Warren, R. B.
    Ink, B.
    Massow, U.
    Assudani, D.
    Fleurinck, C.
    Shende, V.
    Smith, J.
    Peterson, L.
    White, K.
    Landewe, R. B. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1686 - 1687
  • [30] IXEKIZUMAB SIGNIFICANTLY IMPROVES SIGNS, SYMPTOMS AND SPINAL INFLAMMATION OF ACTIVE ANKYLOSING SPONDYLITIS/RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 16-WEEK RESULTS OF A PHASE 3 RANDOMIZED, ACTIVE AND PLACEBO-CONTROLLED TRIAL
    Navarro Compan, Victoria
    Redlich, Kurt
    Bird, Paul
    Bello, Natalia
    Nassab, Mani Haschemi
    Pum, Georg
    Leage, Soyi Liu
    INTERNAL MEDICINE JOURNAL, 2020, 50 : 12 - 13
12345